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Abstract
Background: The limited data on specific dietary components and risk of multiple myeloma (MM) show no consistent
association. Studies have not examined the association of dietary pattern with MM risk.
Methods: In prospective cohorts of 69 751 women (Nurses’ Health Study, 1984–2014) and 47 232 men (Health Professionals
Follow-up Study, 1986–2014), we examined the association between dietary pattern and risk of MM using Cox proportional
hazard models. Diet was assessed repeatedly every 4 years with food frequency questionnaires and was used to calculate dietary patterns including the Alternate Healthy Eating Index-2010, Alternate Mediterranean Diet, Dietary Approaches to Stop
Hypertension, Prudent and Western patterns, the empirical dietary inflammatory pattern (EDIP), and empirical dietary indices for insulin resistance (EDIR) and hyperinsulinemia (EDIH).
Results: During 2 792 257 person-years of follow-up, we identified 478 incident MM cases (215 women, 263 men). In men, high
EDIP was statistically significantly associated with a 16% increase in MM risk (hazard ratio [HR] ¼ 1.16, 95% confidence interval
[CI] ¼ 1.02 to 1.32 per 1-SD increase). Moreover, EDIR and EDIH had a suggestive positive association (EDIR: HR ¼ 1.09, 95% CI ¼
0.96 to 1.24; and EDIH: HR ¼ 1.11, 95% CI ¼ 0.97 to 1.28 per 1-SD increase). We observed no other associations with MM risk in
men and no associations for any dietary pattern with MM risk in women.
Conclusions: We present the first evidence for a role of diets with higher inflammatory or insulinemic potential in MM
development. Further studies are warranted to explore these associations in other populations, including the apparent
restriction to men.

Multiple myeloma (MM) is a plasma cell neoplasm that was
expected to account for more than 30 700 new cancer diagnoses
and more than 12 700 deaths in the United States in 2018 (1).
Although MM survival has improved because of the development of novel treatments, relative 5- and 10-year survival rates
remain as low as 51.6% and 26.8%, respectively (2–7). Further,
current understanding of MM etiology is insufficient to inform
prevention strategies; most established risk factors for MM are
not modifiable (8–10).
In the pathogenesis of MM, upregulation of inflammatory
pathways that mediate nuclear factor-kB and interleukin-6, as
well as dysregulation of endogenous growth factors including

insulin-like growth factor-1 and insulin, have well-documented
roles (11–17). Thus, modifiable factors that modulate these
pathways may also influence MM risk. Obesity, which is characterized by upregulated inflammation and deregulated endogenous growth factors (18,19), has been consistently positively
associated with MM risk (20–22). In fact, obesity is considered
the first and only modifiable risk factor for MM (23) .
Diet may influence MM risk by modulating the aforementioned pathways (24,25). The literature on diet and MM risk is
limited but suggests greater consumption of fish and cruciferous vegetables and less consumption of desserts and sweets
may lower risk (26–28). To our knowledge, no studies have yet
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Methods
Study Population
The Nurses’ Health Study (NHS) began in 1976 when 121 700 female registered nurses aged 30 to 55 years completed the enrollment questionnaire (40). The Health Professionals Follow-up
Study (HPFS) began in 1986 when 51 529 male health professionals aged 40 to 75 years returned the initial questionnaire (41).
Participants in both cohorts completed biennial follow-up questionnaires to update information on lifestyle and medical history, with follow-up rates that exceed 90%. The study protocol
was approved by the institutional review boards of the Brigham
and Women’s Hospital and Harvard T.H. Chan School of Public
Health, and those of participating registries as required.

Dietary Assessment
Diet was assessed by a validated, semiquantitative food frequency questionnaire (FFQ) every 4 years beginning in 1980
(NHS) and 1986 (HPFS) (42–44). Each FFQ contained approximately 130 items (except for the 1980 FFQ; 61 items), for which
standard portion sizes with nine frequency choices ranging
from less than one time per month to six or more times per day
were provided. For this study, we used the data from 1984 (NHS)
and 1986 (HPFS) onward because the expanded number of FFQ
items was important to characterize dietary patterns. All FFQs
returned by participants were uses to compute the dietary patterns described in Table 1.

Covariate Assessment
Adult height and current weight were reported on the enrollment questionnaires, with weight updated biennially. Body

mass index (BMI) was calculated as weight divided by height
squared (kg/m2). Participants reported information on other
covariates such as physical activity and aspirin use from the biennial questionnaires.

Case Identification
We identified most new diagnoses of cancer by self-report on
the biennial questionnaires. A small number of cases were
ascertained via death follow-up. Deaths were identified by
next-of-kin, postal service, or routine searches of the National
Death Index (45,46). For each newly identified case of MM, we
sought permission to obtain the medical records, which were
reviewed by a physician or trained reviewer blinded to exposure
status to confirm the diagnosis and diagnosis date. When medical records were not available, we sought to confirm the diagnosis via linkage to applicable state tumor registries.

Statistical Analysis
Among those who returned FFQs in 1984 (NHS, n ¼ 81 599) and
1986 (HPFS, n ¼ 49 197), we excluded participants with a baseline
history of cancer (n ¼ 4450 women, n ¼ 1965 men) or implausible
total energy intake (n ¼ 7398 women with <500 or >3500 kcal/d;
n ¼ 0 men with <800 or >4200 kcal/d), leaving 69 751 women and
47 232 men in the analyses.
Person-time was calculated from baseline (1984 for NHS,
1986 for HPFS) until the earliest among dates of MM or other
cancer (except non-melanoma skin cancer) diagnosis, death, or
the end of follow-up (June 2014 for NHS, January 2014 for HPFS).
We used cumulative averages of the respective dietary pattern
(updated with repeated measures through the diagnosis or censoring time) to characterize long-term dietary pattern and reduce measurement error (47). Because tests for nonlinearity
using polynomial terms of dietary patterns were not statistically significant, and because the patterns did not have intuitive
a priori categories, we used each dietary pattern as a continuous
variable and modeled risk per 1-SD increase. Cox proportional
hazards regression models stratified on age and questionnaire
cycle were used to compute hazard ratios (HRs) and 95% confidence intervals (CIs) for MM risk associated with the individual
dietary patterns. In multivariable models, we adjusted for potential confounders including cumulative averages of total energy intake (continuous) and BMI (continuous) (22). We
considered as potential covariables but ultimately did not include physical activity (48) and regular aspirin use (49) in the final models because their addition changed the estimates by
less than 1% for most models.
The primary analyses were conducted separately by cohort
(sex); for secondary analyses we pooled the data and included
sex as an additional stratification variable. We performed Wald
tests for interaction by including cross-product terms for the
given dietary pattern and sex. We conducted subgroup analyses
to explore whether the associations between respective dietary
patterns and MM risk differed by BMI (<25 or 25 kg/m2) and
tested for potential interaction by adding the cross-product
term for dietary pattern and BMI to the models. We further examined the association of cross-classified dietary pattern (tertile) and BMI (binary) with MM risk. Lastly, we conducted
sensitivity analyses using tertile of dietary patterns as well as
baseline and recent (closest measures before the diagnosis or
censoring time) dietary patterns.
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examined dietary patterns, rather than intake of individual
foods or nutrients, in relation to MM risk. The study of dietary
pattern as a risk factor has advantages over the study of individual foods or nutrients because dietary pattern accounts for additive, interactive, or synergistic effects of multiple foods and
nutrients and has more intuitive implications for clinical and
public health recommendations (29–32).
Dietary pattern can be characterized using a variety of methods. One approach uses a priori-defined scores based on foods
or nutrients that reflect adherence to a dietary recommendation
or characteristic diet, such as the Alternative Healthy Eating
Index-2010 (AHEI-2010), Alternative Mediterranean Diet (aMED),
and Dietary Approach to Stop Hypertension (DASH) (33–35).
Another approach derives a posteriori-defined dietary patterns,
such as Prudent and Western dietary patterns, using statistical
exploratory methods like principal component analysis (36,37).
An additional approach uses empirically derived dietary indices, including Empirical Dietary Inflammatory Pattern (EDIP),
Empirical Dietary Index for Insulin Resistance (EDIR), and
Empirical Dietary Index for Hyperinsulinemia (EDIH) (38,39).
These dietary indices have shown robust associations with inflammatory and insulin response biomarkers and allow for assessment of the inflammatory (38) or insulinemic potential (39)
of an individual’s diet.
We conducted the current study to examine the association
between a variety of dietary patterns and risk of MM in two
large prospective US cohorts with up to 30 years of follow-up
and repeated assessment of usual adult dietary habits.
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Table 1. Description of dietary patterns*
Type

Principle

aMED

Based on foods and nutrients that reflect a
typical Mediterranean diet (35)

DASH

Based on foods and nutrients that are recommended based on DASH trial, which identified a dietary pattern associated with
reduced risk of hypertension (34)

A posteriori-defined dietary patterns
Prudent
Based on FFQs (approximately 40 food
groups) using principle component analysis with orthogonal transformation (36, 37)

Western

As above

Empirically derived dietary indices
EDIP
Based on 39 predefined food groups from
FFQs (38, 39)

EDIR

As above

EDIH

As above

Emphasizes higher consumption of vegetables, fruits, whole grains, nuts and
legumes, long-chain omega-3 fatty acids, and polyunsaturated fatty acids
and lower consumption of sugar-sweetened beverages, red and processed
meat, sodium, trans fat, and moderate alcohol, as captured by the FFQ.
Each component scored from 0 to 10 points based on predefined criteria.
Total score ranged from 0 to 110 points, with a higher score considered to represent a healthier diet.
Awards 1 point per item consumed at a level above cohort-specific median
for vegetables, legumes, fruits, nuts, whole grains, fish, and monounsaturated fat-to-saturated fat ratio and for intake below cohort-specific median
for red/processed meats. For alcohol intake, score awards 1 point if intake
5–15 g/d for women and 10–25 g/d for men.
Total score ranged from 0 to 9 points; higher score represents closer adherence to Mediterranean (and favorable) diet.
Awards points for high intake of fruits, vegetables, nuts and legumes, low-fat
dairy products, and whole grains, and for low intake of red/processed
meats, sweets, and sodium. For each component, participants in the lowest cohort-specific quintile received 1 point and those in the highest quintile
received 5 points for consumption of healthy food or nutrient; scoring was
reversed for unhealthy foods or nutrients.
Total score ranged 8–40 points; higher scores considered more favorable to
hypertension prevention.
Consultation of eigenvalues and scree plot identified 2 major dietary patterns
to retain for analysis: Prudent pattern (high intake of vegetables, fruits,
legumes, whole grains, and fish) and Western pattern (high intake of red/
processed meats, high-fat dairy products, refined grains, and sweets/
desserts).
Individual scores calculated for each pattern based on reported food intakes
and corresponding factor loadings of the foods.

EDIP was derived using reduced rank regression and stepwise linear regression to identify food groups most predictive of 3 inflammatory markers (interleukin-6, C-reactive protein, and tumor necrosis factor-alpha receptor).
Nine food groups were positively associated (processed and red meat, refined grains, high-energy beverages, etc.), and 9 food groups were inversely
associated (coffee, wine, leafy green vegetables, etc.).
EDIR was derived using stepwise linear regression to identify food groups
most predictive of hyperinsulinemia (C-peptide). Ten food groups were
positively associated (processed and red meat, non-fatty fish, margarine,
creamy soup, etc.), and 8 food groups were inversely associated (wine,
beer, dark yellow vegetables, etc.).
EDIH was derived using stepwise linear regression to identify food groups
most predictive of a surrogate of insulin resistance (triglyceride to HDL
cholesterol ratio). Thirteen food groups were positively associated (processed and red meat, poultry, non-fatty fish, creamy soup, french fries, etc.),
and 5 food groups were inversely associated (wine, green leafy vegetables,
high-fat dairy, etc.).
Food groups identified as most strongly predicting circulating levels of corresponding biomarkers were weighted by regression coefficients obtained
from final stepwise linear regression model and then summed to create
the score. More positive scores indicate a more inflammatory or insulinemic (ie, associated with hyperinsulinemia or insulin resistance) diet; more
negative scores indicate a less inflammatory or insulinemic diet. A summary of the identified food groups is provided in Supplementary Table 3
(available online).

*AHEI ¼ alternate healthy eating index-2010; aMED ¼ alternate Mediterranean diet; DASH ¼ dietary approaches to stop hypertension; EDIH ¼ empirical dietary index
for hyperinsulinemia; EDIP ¼ empirical dietary inflammatory pattern; EDIR ¼ empirical dietary index for insulin resistance; FFQ ¼ food frequency questionnaire; HDL ¼
high-density lipoprotein.
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A priori-defined scores
AHEI-2010
Based on 11 dietary components shown to
be associated with lower risk of chronic
disease (33)

Calculation
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Table 2. Age-standardized baseline characteristics of participants*

Characteristic

HPFS (47 232
men)

50.7 (7.1)
25.0 (4.6)
12.7 (15.2)
40.1

54.4 (9.7)
25.6 (3.3)
20.9 (29.1)
20.0

1749 (523)
6.9 (11.2)
2.2 (2.3)
4.5 (2.8)
2.1 (1.7)
2.2 (1.8)
6.5 (7.1)
8.4 (7.1)
9.9 (7.4)
16.6 (10.5)
7.6 (7.3)
6.4 (6.8)
2.2 (3.3)
17.5 (13.6)
2.1 (4.1)

1989 (619)
11.3 (15.4)
2.6 (3.0)
4.3 (3.2)
2.5 (2.0)
2.9 (2.3)
10.0 (9.7)
8.6 (7.5)
11.3 (9.1)
21.7 (15.2)
6.8 (7.2)
7.0 (7.5)
3.4 (4.8)
29.3 (20.5)
2.5 (4.2)

*Data were presented as mean (SD) (unless otherwise specified). BMI ¼ body
mass index; HPFS ¼ Health Professionals Follow-Up Study; MET ¼ metabolic
equivalent task; NHS ¼ Nurses’ Health Study; SSB ¼ sugar-sweetened beverage.
†Age was not standardized.
‡Updated information over the follow-up due to no baseline information in men.

HR (95% CI) per 1-SD increase*,†
Dietary pattern
AHEI-2010
Age- and energy-adjusted‡
Multivariable-adjusted§
aMED
Age- and energy-adjusted‡
Multivariable-adjusted§
DASH
Age- and energy-adjusted‡
Multivariable-adjusted§
Prudent
Age- and energy-adjusted‡
Multivariable-adjusted§
Western
Age- and energy-adjusted‡
Multivariable-adjusted§
EDIP
Age- and energy-adjusted‡
Multivariable-adjusted§
EDIR
Age- and energy-adjusted‡
Multivariable-adjusted§
EDIH
Age- and energy-adjusted‡
Multivariable-adjusted§

Women

Men

1.02 (0.89 to 1.18)
1.04 (0.90 to 1.20)

1.03 (0.91 to 1.17)
1.05 (0.93 to 1.20)

0.97 (0.83 to 1.13)
0.99 (0.84 to 1.15)

0.95 (0.83 to 1.08)
0.96 (0.84 to 1.10)

0.98 (0.85 to 1.14)
1.00 (0.86 to 1.16)

0.93 (0.82 to 1.06)
0.95 (0.83 to 1.08)

0.95 (0.80 to 1.11)
0.95 (0.80 to 1.11)

0.95 (0.83 to 1.10)
0.96 (0.84 to 1.11)

1.06 (0.87 to 1.30)
1.03 (0.84 to 1.26)

1.05 (0.89 to 1.24)
1.02 (0.86 to 1.21)

1.06 (0.91 to 1.23)
1.01 (0.87 to 1.18)

1.18 (1.03 to 1.35)
1.16 (1.02 to 1.32)

1.00 (0.86 to 1.17)
0.95 (0.80 to 1.11)

1.11 (0.98 to 1.27)
1.09 (0.96 to 1.24)

1.08 (0.91 to 1.28)
1.02 (0.86 to 1.22)

1.14 (0.99 to 1.31)
1.11 (0.97 to 1.28)

*Sex-specific SD was used. AHEI ¼ alternate healthy eating index-2010; aMED ¼

All statistical analyses were performed using SAS 9.4 (SAS
Institute) and assumed a two-tailed alpha error of 0.05.

Results
We confirmed incident MM in 215 women (NHS) and 263 men
(HPFS) over 30 years of follow-up (1 709 737 person-years in NHS;
1 082 520 person-years in HPFS). The mean age was slightly
younger for women (50.7 years) than men (54.4 years). The
mean BMI was similar (approximately 25–26 kg/m2) for women
and men (Table 2). Participants with a higher AHEI-2010, aMED,
DASH, and Prudent pattern tended to have lower BMI; higher
physical activity; lower intakes of red and processed meat, refined carbohydrates, and sugar-sweetened beverage; and higher
intakes of whole grains, fruits, and vegetables (Supplementary
Table 1, available online). Western pattern, EDIP, EDIR, and
EDIH showed opposite trends in general, with no marked differences by sex.
Moderate to high correlations were evident among AHEI2010, aMED, DASH, and Prudent patterns (Spearman
correlation ¼ 0.51 to 0.80) (Supplementary Table 2, available online). These patterns were inversely correlated with the
Western pattern, EDIP, and EDIH. Further, there were moderate
to high correlations among three empirical dietary indices
(Spearman correlation ¼ 0.57 to 0.76).
In the cohort (sex)-specific analyses of dietary pattern and
MM risk, we observed a statistically significant positive association for cumulative average EDIP in men (Table 3). After adjusting for age, energy intake, and BMI, each 1-SD increase of
cumulative average EDIP was associated with a 16% increased
risk of MM (HR ¼ 1.16, 95% CI ¼ 1.02 to 1.32). EDIR and EDIH had
suggestive positive associations with MM risk in men in
the fully adjusted models (EDIR: HR per 1-SD increase ¼ 1.09,

alternate Mediterranean diet; BMI ¼ body mass index; CI ¼ confidence interval;
DASH ¼ dietary approaches to stop hypertension; EDIH ¼ empirical dietary index for hyperinsulinemia; EDIP ¼ empirical dietary inflammatory pattern; EDIR
¼ empirical dietary index for insulin resistance; HR ¼ hazard ratio.
†Case per person-years: 215 per 1 709 737 for women; 263 per 1 082 520 for men.
‡Adjusted for age in years and cumulative average energy intake (continuous).
§Additionally adjusted for cumulative average BMI (continuous).

95% CI ¼ 0.96 to 1.24; EDIH: HR per 1-SD increase ¼ 1.11, 95% CI ¼
0.97 to 1.28). Other dietary patterns were not statistically significantly associated with MM risk in men. In women, none of the
dietary patterns had statistically significant associations with
MM risk (Table 3).
When we examined the association of cross-classified dietary patterns and BMI in relation to MM risk, we found statistically significant associations of EDIP and EDIH cross-classified
with BMI in men (Table 5). Compared with lean men in the lowest (eg, “healthiest”) tertile of EDIP and EDIH, overweight or
obese men in the highest (eg, “least healthy”) tertile had a 96%
and 74% increased risk of MM, respectively (EDIP: HR ¼ 1.96, 95%
CI ¼ 1.22 to 3.13; EDIH: HR ¼ 1.74, 95% CI ¼ 1.10 to 2.75). We
found no other statistically significant association for BMI
cross-classified with dietary patterns for men or women
(Tables 4 and 5). When we stratified the analyses by BMI, the association between dietary pattern and MM risk did not differ
statistically significantly by BMI in men, although EDIP, EDIR,
and EDIH tended to show stronger positive associations with
MM risk for lean than for heavier men (Supplementary Table 4,
available online).
In the sensitivity analyses using baseline and recent dietary
pattern, the baseline EDIP, EDIR, and EDIH showed statistically
significant positive associations with MM risk for men but no
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Age, y†
BMI, kg/m2
Physical activity, MET-h/wk
Regular aspirin use, % ‡
Diet intake
Calorie intake, kcal/d
Alcohol, g/d
Processed meat, servings/wk
Red meat, servings/wk
Poultry, servings/wk
Fish, servings/wk
Whole grain, servings/wk
Refined carbohydrates, servings/wk
Fruits, servings/wk
Vegetables, servings/wk
High-fat dairy, servings/wk
Low-fat dairy, servings/wk
Nuts, servings/wk
Coffee, servings/wk
SSB, servings/wk

NHS (69 751
women)

Table 3. Association between cumulative average dietary pattern
and multiple myeloma risk in women and men
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Table 4. Association of cross-classified cumulative average dietary pattern and BMI with multiple myeloma risk in women

Presumed healthy dietary patterns*

Presumed unhealthy dietary patterns*
Western
BMI<25
Cases
HR (95% CI)
BMI25
Cases
HR (95% CI)
EDIP
BMI<25
Cases
HR (95% CI)
BMI25
Cases
HR (95% CI)
EDIR
BMI<25
Cases
HR (95% CI)
BMI25
Cases
HR (95% CI)
EDIH
BMI<25
Cases
HR (95% CI)
BMI25
Cases
HR (95% CI)

Medium

Unhealthiest

Tertile 3

Tertile 2

Tertile 1

34
1 (reference)*

38
1.34 (0.84 to 2.14)

24
0.96 (0.56 to 1.62)

39
1.36 (0.86 to 2.16)

40
1.27 (0.80 to 2.01)

40
1.35 (0.85 to 2.14)

32
1 (reference)*

38
1.21 (0.75 to 1.95)

26
0.94 (0.55 to 1.61)

40
1.38 (0.86 to 2.20)

37
1.14 (0.71 to 1.85)

42
1.30 (0.81 to 2.11)

33
1 (reference)*

35
1.22 (0.76 to 1.98)

28
1.11 (0.66 to 1.85)

44
1.47 (0.93 to 2.31)

35
1.12 (0.69 to 1.81)

40
1.43 (0.89 to 2.28)

30
1 (reference)*

31
1.07 (0.64 to 1.79)

35
1.21 (0.72 to 2.02)

42
1.33 (0.83 to 2.14)

38
1.21 (0.74 to 1.98)

39
1.41 (0.85 to 2.33)

Tertile 1

Tertile 2

Tertile 3

37
1 (reference)*

38
1.29 (0.81 to 2.06)

21
0.91 (0.50 to 1.66)

34
1.05 (0.66 to 1.68)

47
1.51 (0.97 to 2.36)

38
1.34 (0.79 to 2.26)

28
1 (reference)*

37
1.56 (0.95 to 2.56)

31
1.89 (1.13 to 3.16)

36
2.00 (1.21 to 3.28)

37
1.50 (0.92 to 2.47)

46
1.67 (1.04 to 2.69)

34
1 (reference)*

43
1.60 (1.01 to 2.52)

19
1.06 (0.59 to 1.90)

38
1.74 (1.09 to 2.78)

36
1.29 (0.80 to 2.07)

45
1.43 (0.90 to 2.27)

34
1 (reference)*

36
1.46 (0.90 to 2.36)

26
1.62 (0.94 to 2.78)

38
1.75 (1.10 to 2.78)

42
1.52 (0.96 to 2.40)

39
1.41 (0.87 to 2.30)

*All models adjusted for age in years and cumulative average energy intake (continuous). Reference group is those with low BMI and the healthiest dietary pattern. For
the presumed healthy dietary patterns in the top half of the table, the reference group includes participants with a low BMI and a dietary pattern score in the highest tertile
(eg, greatest adherence to the healthy dietary pattern), whereas the highest-risk group includes participants with a higher BMI and a dietary pattern score in the lowest tertile (eg, least adherence to the healthier dietary pattern). For the presumed unhealthy dietary patterns in the lower half of the table, the reference group includes participants with a low BMI and a dietary pattern score in the lowest tertile (eg, least adherence to the less healthy dietary pattern), whereas the highest-risk group includes
participants with a higher BMI and a dietary pattern score in the highest tertile (eg, greatest adherence to the less healthy dietary pattern). AHEI-2010 ¼ alternate healthy
eating index-2010; aMED ¼ alternate Mediterranean diet; BMI ¼ body mass index; CI ¼ confidence interval; DASH ¼ dietary approaches to stop hypertension; EDIH ¼ empirical dietary index for hyperinsulinemia; EDIP ¼ empirical dietary inflammatory pattern; EDIR ¼ empirical dietary index for insulin resistance; HR ¼ hazard ratio.
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AHEI-2010
BMI<25
Cases
HR (95% CI)
BMI25
Cases
HR (95% CI)
aMED
BMI<25
Cases
HR (95% CI)
BMI25
Cases
HR (95% CI)
DASH
BMI<25
Cases
HR (95% CI)
BMI25
Cases
HR (95% CI)
Prudent
BMI<25
Cases
HR (95% CI)
BMI25
Cases
HR (95% CI)

Healthiest
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Table 5. Association of cross-classified cumulative average dietary pattern and BMI with multiple myeloma risk in men

Presumed healthy dietary patterns*

Presumed unhealthy dietary patterns*
Western
BMI <25
Cases
HR (95% CI)
BMI 25
Cases
HR (95% CI)
EDIP
BMI <25
Cases
HR (95% CI)
BMI 25
Cases
HR (95% CI)
EDIR
BMI <25
Cases
HR (95% CI)
BMI 25
Cases
HR (95% CI)
EDIH
BMI <25
Cases
HR (95% CI)
BMI 25
Cases
HR (95% CI)

Medium

Unhealthiest

Tertile 3

Tertile 2

Tertile 1

39
1 (reference)*

36
1.21 (0.76 to 1.91)

25
1.00 (0.60 to 1.66)

60
1.55 (1.03 to 2.33)

55
1.27 (0.84 to 1.93)

48
1.12 (0.73 to 1.72)

37
1 (reference)*

32
0.98 (0.60 to 1.58)

31
1.27 (0.78 to 2.08)

52
1.31 (0.86 to 2.01)

58
1.29 (0.85 to 1.96)

53
1.31 (0.85 to 2.02)

36
1 (reference)*

40
1.64 (1.04 to 2.59)

24
1.24 (0.73 to 2.09)

52
1.47 (0.95 to 2.25)

62
1.67 (1.10 to 2.54)

49
1.47 (0.94 to 2.29)

39
1 (reference)*

35
1.10 (0.69 to 1.76)

26
0.98 (0.58 to 1.64)

61
1.35 (0.90 to 2.03)

55
1.25 (0.82 to 1.91)

47
1.16 (0.74 to 1.83)

Tertile 1

Tertile 2

Tertile 3

38
1 (reference)*

28
1.34 (0.80 to 2.23)

34
1.54 (1.02 to 2.32)

47
0.97 (0.59 to 1.60)

65
1.29 (0.84 to 1.99)

51
1.16 (0.72 to 1.86)

24
1 (reference)*

40
1.71 (1.01 to 2.88)

36
1.62 (0.99 to 2.65)

46
1.55 (0.93 to 2.58)

49
1.55 (0.94 to 2.56)

68
1.96 (1.22 to 3.13)

33
1 (reference)*

37
1.06 (0.64 to 1.76)

30
1.42 (0.92 to 2.19)

46
1.06 (0.66 to 1.71)

57
1.17 (0.75 to 1.84)

60
1.24 (0.80 to 1.93)

32
1 (reference)*

34
1.83 (1.10 to 3.05)

34
1.62 (1.04 to 2.52)

48
1.38 (0.84 to 2.25)

56
1.53 (0.97 to 2.40)

59
1.74 (1.10 to 2.75)

*All models adjusted for age in years and cumulative average energy intake (continuous). Reference group is those with low BMI and the healthiest dietary pattern. For the
presumed healthy dietary patterns in the top half of the table, the reference group includes participants with a low BMI and a dietary pattern score in the highest tertile (eg,
greatest adherence to the healthy dietary pattern), whereas the highest-risk group includes participants with a higher BMI and a dietary pattern score in the lowest tertile
(eg, least adherence to the healthier dietary pattern). For the presumed unhealthy dietary patterns in the lower half of the table, the reference group includes participants
with a low BMI and a dietary pattern score in the lowest tertile (eg, least adherence to the less healthy dietary pattern), whereas the highest-risk group includes participants
with a higher BMI and a dietary pattern score in the highest tertile (eg, greatest adherence to the less healthy dietary pattern). AHEI-2010 ¼ alternate healthy eating index2010; aMED ¼ alternate Mediterranean diet; BMI ¼ body mass index; CI ¼ confidence interval; DASH ¼ dietary approaches to stop hypertension; EDIH ¼ empirical dietary index for hyperinsulinemia; EDIP ¼ empirical dietary inflammatory pattern; EDIR ¼ empirical dietary index for insulin resistance; HR ¼ hazard ratio.
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AHEI-2010
BMI <25
Cases
HR (95% CI)
BMI 25
Cases
HR (95% CI)
aMED
BMI <25
Cases
HR (95% CI)
BMI 25
Cases
HR (95% CI)
DASH
BMI <25
Cases
HR (95% CI)
BMI25
Cases
HR (95% CI)
Prudent
BMI<25
Cases
HR (95% CI)
BMI25
Cases
HR (95% CI)

Healthiest
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Discussion
In two large US prospective cohorts, we observed a statistically
significantly positive association between EDIP, a dietary index
associated with pro-inflammatory biomarkers, and MM risk in
men. EDIR and EDIH, dietary indices associated positively with
insulin-related biomarkers, showed suggestive positive associations with MM risk in men. Other dietary patterns were not statistically significantly associated with MM in men, and we did
not find any statistically significant association of dietary pattern with MM risk in women.
To our knowledge, no studies to date have examined the association between dietary pattern and MM risk. Further, relatively few published studies have examined the association of
individual foods or nutrients with MM risk. Of those, several
case-control studies have reported that higher intake of vegetables (50,51), especially cruciferous vegetables (26,27), and fish
(26–28,50,52) were associated with a lower risk of MM, whereas
higher intake of some dairy products were positively associated
with higher risk of MM (26). Overall, current knowledge on the
association between diet and MM risk is limited and inconclusive. Moreover, the previous studies had relatively small sample
size and low response rates. Also, recall bias cannot be ruled out
for case-control studies; recall of diet may differ by disease status, because patients generally have cultivated a sense of which
foods are healthy or unhealthy.
In the present study, we evaluated the association of diet
with MM risk using dietary pattern rather than individual foods
or nutrients. Our finding of a positive association of the EDIP in
men is consistent with our hypothesis that immunemodulating or pro-inflammatory factors influence MM risk
(13,53,54). Of interest, dysregulation of endogenous growth factors such as insulin-like growth factor-1 and insulin also contributes to MM pathogenesis (12,15,16,55), lending plausibility to
our observation of suggestive positive associations with MM
risk for EDIR and EDIH, which were derived to characterize the
insulinemic potential of diet, particularly related to insulin resistance and hyperinsulinemia, respectively (39). The latter
associations also had apparent restrictions to men.
Interestingly, we observed statistically significant and plausible associations of cross-classifications of EDIP and obesity,
and of EDIH and obesity, with MM risk, also predominantly in
men. Obesity is the only established modifiable risk factor for
MM (23,56). Although we had limited power for those analyses,
we consistently observed that individuals with the greatest dietary potential for heightened inflammation or hyperinsulinemia
and also higher BMI had the greatest increase in MM risk.
Higher adiposity is associated with higher levels of pro-

inflammatory cytokines and endogenous growth factors and
with lower levels of circulating adiponectin. It is biologically
plausible that low dietary quality in the setting of greater adiposity has synergistic adverse effects on MM pathogenesis.
Another interesting observation was that stratified analyses
generally showed a stronger positive association between inflammatory or insulinemic diets and MM risk in lean individuals compared with overweight or obese individuals. Although
the interactions between these diet patterns and BMI were
mostly not statistically significant, these findings suggest that
inflammatory or insulinemic diets may be a stronger risk factor
of MM in individuals with lower adiposity.
The other dietary patterns that we examined in this study did
not have a clear association with MM risk in men or in women.
Previous studies have shown an inverse association of AHEI2010, aMED, DASH, and Prudent patterns, as well as a positive association of Western pattern, with major chronic diseases and
certain solid tumors (32,33,57–61). Further, these dietary patterns
were shown to be associated with inflammation (24,62). Thus,
our null findings were somewhat unexpected and inconsistent
with those for other chronic diseases. Reassuringly, our findings
for AHEI-2010, aMED, and DASH did not suggest an increased risk
of MM, supporting that adherence to current recommendations
of dietary patterns based on scientific evidence for the prevention of chronic diseases does not confer harm from MM risk. The
reasons for the discrepancy of findings for the dietary pattern
scores and for EDIP, EDIR, and EDIH are not immediately clear.
The latter dietary indices were directly derived from food groups
that are most predictive of biomarkers of inflammation, insulin
resistance, and hyperinsulinemia, respectively, and thus may
more directly or more precisely capture the immune-modulating
aspects of diet that are most relevant to MM development.
Alternatively, more limited variability in the other dietary score
variables, and possibly residual confounding by unknown or
unmeasured risk factors, may have hindered detection of a subtler association of other dietary patterns with MM risk.
Unlike in men, dietary patterns did not show any association
or trend in relation to MM risk in women, except that we found
a statistically significantly positive association of EDIP and EDIH
with MM risk among lean women. The observed sex difference
may be due to chance or to uncontrolled confounding by as-yetunknown risk factors for MM that vary by sex. Alternatively, the
findings may reflect true sex differences in physiologic effects
of dietary pattern on the development of MM. In our cohorts, we
have seen sex differences for other risk factors for MM. For example, both young adult and later adult BMI were stronger risk
factors for men compared with women (22). Furthermore, regular aspirin intake showed stronger inverse association with MM
risk in men than in women (49). Overall, the literature is variable
with regard to reports of sex differences in these factors and
does not offer clarification of our present findings. However, we
note that MM incidence is generally 40–50% higher in men than
in women (7). With the present sample sizes, we had limited
statistical power to detect statistically significant interactions of
dietary pattern and sex. Our secondary analyses pooling the
data for women and men did not replicate the statistically significant findings in men. The present observation of sex differences for the dietary index associations with MM risk requires
further exploration in larger study populations.
This study has considerable strengths. Detailed diet data
allowed us to compute and compare a variety of dietary patterns to examine their association with MM risk. Further, repeated measures of dietary pattern were available over a long
follow-up period, permitting an examination of the influence of
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associations for women (Supplementary Table 5, available online). In contrast, recent dietary patterns were not associated
with MM risk in women or men (Supplementary Table 6, available online). Analyses of tertile of dietary patterns showed
results consistent with those already described (Supplementary
Tables 7 and 8, available online). In the analyses of pooled data,
we found no association between cumulative average dietary
patterns and MM risk overall (Supplementary Table 9, available
online) or when jointly classified with BMI (Supplementary
Table 10, available online). However, 1-SD increases of EDIP,
EDIR, and EDIH were statistically significantly associated with
an 18–29% increased risk of MM in lean participants in the
pooled analyses stratified by BMI (Supplementary Table 11,
available online).

8 of 9 | JNCI Cancer Spectrum, 2019, Vol. 3, No. 2

Funding
This work was supported by the National Institutes of
Health (UM1 CA167552, R01 HL35464, UM1 CA186107, P01
CA87969, K99 CA207736, R00 CA207736, and R21 CA198239).

Notes
Affiliations of authors: Department of Nutrition, Harvard T.H.
Chan School of Public Health, Boston, MA (DHL, TTF, FKT, ELG);
Department of Nutrition, Simmons University, Boston, MA
(TTF); Division of Medical Oncology, Department of Internal
Medicine, The Ohio State University College of Medicine,
Columbus, OH (FKT); Department of Public Health Sciences,
Washington University School of Medicine, St. Louis, MO (GAC);
Dana-Farber Cancer Institute, Harvard Medical School, Boston,
MA (IMG); Channing Division of Network Medicine, Department
of Medicine, Brigham and Women’s Hospital and Harvard
Medical School, Boston, MA (BAR, ELG, BMB); Department of
Epidemiology, Harvard T.H. Chan School of Public Health,
Boston, MA (ELG).
We would like to thank the following state cancer registries
for their help: AL, AZ, AR, CA, CO, CT, DE, FL, GA, ID, IL, IN, IA,
KY, LA, ME, MD, MA, MI, NE, NH, NJ, NY, NC, ND, OH, OK, OR, PA,
RI, SC, TN, TX, VA, WA, WY. The authors assume full responsibility for analyses and interpretation of these data.
The authors declared no conflicts of interest.

References
1. Siegel RL, Miller KD, Jemal AA-O. CA Cancer J Clin. 2018;68(1):7–30.
2. Bosetti C, Bertuccio P, Malvezzi M, et al. Cancer mortality in Europe, 2005–
2009, and an overview of trends since 1980. Ann Oncol. 2013;24(10):2657–2671.
3. Kaya H, Peressini B, Jawed I, et al. Impact of age, race and decade of treatment
on overall survival in a critical population analysis of 40,000 multiple myeloma patients. Int J Hematol. 2012;95(1):64–70.
4. Pozzi S, Marcheselli L, Bari A, et al. Survival of multiple myeloma patients
in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis. Br J Haematol. 2013;163(1):
40–46.
5. Pulte D, Gondos A, Brenner H. Improvement in survival of older adults with
multiple myeloma: results of an updated period analysis of SEER data.
Oncologist. 2011;16(11):1600–1603.
6. Pulte D, Redaniel MT, Brenner H, et al. Recent improvement in survival of
patients with multiple myeloma: variation by ethnicity. Leuk Lymphoma.
2014;55(5):1083–1089.
7. Noone A, Howlader N, Krapcho M, et al. SEER Cancer Statistics Review, 19752015, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/
1975_2015/, based on November 2017 SEER data submission, posted to the
SEER web site, April 2018.
8. Batista JL, Birmann BM, Epstein MM. Epidemiology of hematologic malignancies. In: Loda M, Mucci LA, Mittelstadt ML, Van Hemelrijck M, Cotte MB (eds).
Pathology and Epidemiology of Cancer. Cham, Switzerland:Springer
International Publishing AG; 2017:543–569.
9. Vachon CM, Kyle RA, Therneau TM, et al. Increased risk of monoclonal
gammopathy in first-degree relatives of patients with multiple myeloma or
monoclonal gammopathy of undetermined significance. Blood. 2009;114(4):
785–790.
10. Schinasi LH, Brown EE, Camp NJ, et al. Multiple myeloma and family history
of lymphohaematopoietic cancers: results from the International Multiple
Myeloma Consortium. Br J Haematol. 2016;175(1):87–101.
11. Bataille R, Robillard N, Avet-Loiseau H, et al. CD221 (IGF-1R) is aberrantly
expressed in multiple myeloma, in relation to disease severity.
Haematologica. 2005;90(5):706–707.
12. Ge N-L, Rudikoff S. Insulin-like growth factor I is a dual effector of multiple
myeloma cell growth. Blood. 2000;96(8):2856–2861.
13. Hirano T. Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias. Int J Cell Cloning. 1991;9(3):166–184.
14. Kawano M, Hirano T, Matsuda T, et al. Autocrine generation and requirement
of BSF-2/IL-6 for human multiple myelomas. Nature. 1988;332(6159):83–85.
15. Qiang Y-W, Kopantzev E, Rudikoff S. Insulinlike growth factor–I signaling in
multiple myeloma: downstream elements, functional correlates, and pathway cross-talk. Blood. 2002;99(11):4138–4146.
16. Qiang Y-W, Yao L, Tosato G, et al. Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells. Blood. 2004;103(1):
301–308.
17. Sprynski AC, Hose D, Kassambara A, et al. Insulin is a potent myeloma cell
growth factor through insulin/IGF-1 hybrid receptor activation. Leukemia.
2010;24(11):1940.
18. Lichtman MA. Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma. Oncologist. 2010;15(10):1083–1101.
19. De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes.
2013;2013:1.
20. Wallin A, Larsson SC. Body mass index and risk of multiple myeloma: a
meta-analysis of prospective studies. Eur J Cancer. 2011;47(11):
1606–1615.
21. Hofmann JN, Moore SC, Lim U, et al. Body mass index and physical activity at
different ages and risk of multiple myeloma in the NIH-AARP diet and health
study. Am J Epidemiol. 2013;177(8):776–786.
22. Marinac CR, Birmann BM, Lee IM, et al. Body mass index throughout adulthood, physical activity, and risk of multiple myeloma: a prospective analysis
in three large cohorts. Br J Cancer. 2018;118(7):1013–1019.
23. Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body fatness and cancerviewpoint of the IARC Working Group. N Engl J Med. 2016;375(8):794–798.
24. Barbaresko J, Koch M, Schulze MB, et al. Dietary pattern analysis and biomarkers of low-grade inflammation: a systematic literature review. Nutr Rev.
2013;71(8):511–527.
25. Galland L. Diet and inflammation. Nutr Clin Pract. 2010;25(6):634–640.
26. Hosgood HD, Baris D, Zahm SH, et al. Diet and risk of multiple myeloma in
Connecticut women. Cancer Causes Control. 2007;18(10):1065–1076.
27. Brown LM, Gridley G, Pottern LM, et al. Diet and nutrition as risk factors for
multiple myeloma among blacks and whites in the United States. Cancer
Causes Control. 2001;12(2):117–125.
28. Caini S, Masala G, Gnagnarella P, et al. Food of animal origin and risk of nonHodgkin lymphoma and multiple myeloma: a review of the literature and
meta-analysis. Crit Rev Oncol Hematol. 2016;100:16–24.
29. Randall E, Marshall JR, Brasure J, et al. Dietary patterns and colon cancer in
western New York. Nutr Cancer. 1992;18(3):265–276.
30. Sacks FM, Obarzanek E, Windhauser MM, et al. Rationale and design of the
Dietary Approaches to Stop Hypertension trial (DASH): a multicenter

Downloaded from https://academic.oup.com/jncics/article-abstract/3/2/pkz025/5480692 by Washington University in St. Louis user on 15 November 2019

timing of “exposure.” In fact, the associations for EDIP, EDIR,
and EDIH appeared somewhat stronger for baseline measures
than for the cumulative averages, whereas the associations
were attenuated when based only on the most recent dietary
assessment. The latter observation may reflect an influence of
subclinical disease on dietary habits, though the most recent dietary assessment tended, on average, to be approximately
2 years before diagnosis of MM. The findings may also suggest
an earlier critical period for an influence of dietary pattern on
MM development, although we did not have sufficient statistical
power to stratify the analyses by follow-up interval to elucidate
this further. Other strengths include the prospective design and
the homogeneity of the study population that makes residual
confounding by race/ethnicity unlikely. Several limitations also
warrant attention. First, measurement error in assessing dietary
pattern is inevitable. However, use of cumulative average of repeated measures may reduce the measurement error of longterm intake. Given the prospective study design, the measurement error is likely nondifferential. Second, although we adjusted for some known and potential confounders, we cannot
rule out residual confounding by unknown or unmeasured factors such as family history of lymphoid malignancy (9,10). Lastly,
our study population consisted of predominantly white health
professionals, which may limit the generalizability of the findings if dietary pattern is correlated with aspects of race or
ethnicity that also underlie its association with MM.
In conclusion, our findings show evidence that diets with inflammatory or insulinemic potential may play a role in MM development, with apparent restrictions to men. Our study
warrants confirmation in populations with larger sample size
and greater racial and ethnic diversity as well as in relation to
risk of progression from monoclonal gammopathy of undetermined significance to MM.
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